NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.

Private
ChengduHealthcare & Life Sciences

Last Round

Series A

May 27, 2026

Total Funding Raised

$13.8M

Company Overview

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. is a biotechnology company that researches and develops next-generation universal cell therapy products, including therapeutic cell vaccines and in vivo CAR-T platforms for oncology treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in vivo CAR-Tcell therapyCAR-Ttherapeutic cell vaccinesgene therapynext-gen CAR-Timmunotherapyoncologybiotechnologydrug discoveryprecision medicineclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Comparables

Compare Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CREATE Medicines
81%
Shenzhen MagicRNA Biotechnology Co., Ltd.
80%
Umoja Biopharma
78%

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 27, 2026
SeedOct 17, 2023

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Investors

Notable investors and investment history

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. investors
InvestorRounds
YuanBio Venture CapitalSeries A
Legend CapitalSeries A, Seed
Shengjing JiachengSeries A

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Chengdu Zhenyu Biopharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChengdu
Year Founded2023
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.